SKI Market

A+| A| A-|

Indian Indices

Sensex

78,493.54 504.86
( 0.65%)

Global Indices

Nasdaq

49,467.44 867.71
(1.79%)

Dow Jones

7,146.92 84.64
(1.20%)

Hang Seng

58,837.37 -680.97
(-1.14%)

Nikkei 225

10,660.47 70.48
(0.67%)

Forex

USD-INR

93.19 -0.12
(-0.13%)

EUR-INR

109.85 -0.18
(-0.16%)

GBP-INR

126.25 -0.31
(-0.25%)

JPY-INR

0.59 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Shilpa Medicare Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

530549

INE790G01031

137.4709721

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SHILPAMED

72.84

8049.17

EPS(TTM)

Face Value()

Div & Yield %

5.65

0.12

Back

Uflex reports consolidated net profit of Rs 26.91 crore in the September 2025 quarter

Nov 14,2025

Net profit of Uflex reported to Rs 26.91 crore in the quarter ended September 2025 as against net loss of Rs 64.62 crore during the previous quarter ended September 2024. Sales declined 0.96% to Rs 3744.63 crore in the quarter ended September 2025 as against Rs 3781.03 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	3744.63	3781.03	-1
OPM %	10.32	10.38	-
PBDT	227.19	234.79	-3
PBT	37.78	61.64	-39
NP	26.91	-64.62	LP

78,493.54 504.86 ( 0.65%)

49,467.44 867.71 (1.79%)

7,146.92 84.64 (1.20%)

58,837.37 -680.97 (-1.14%)

10,660.47 70.48 (0.67%)

93.19 -0.12 (-0.13%)

109.85 -0.18 (-0.16%)

126.25 -0.31 (-0.25%)

0.59 0.00 (-0.15%)